Annual Report 2012.pdf - Karo Bio
Annual Report 2012.pdf - Karo Bio
Annual Report 2012.pdf - Karo Bio
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Corporate Governance <strong>Report</strong><br />
Executive Managers and Auditors<br />
Per Bengtsson<br />
Maria Öhlander<br />
Maria Sjöberg<br />
Henrik Palm<br />
Lars Öhman<br />
Per Bengtsson (1954)<br />
President and CEO. Elected in 2011.<br />
Education: M.D. Ph.D. (Cell <strong>Bio</strong>logy).<br />
Primary experience: CEO Probi AB (publ), R&D<br />
Manager Pharmacia/Pharmacia&Upjohn Plasma<br />
Products, Medical Manager and Therapeutic Manager<br />
at Ferring and Development Manager at <strong>Bio</strong>nor<br />
Immuno A/S.<br />
Other assignments: Board member Pharma vizer<br />
AB.<br />
Number of shares in <strong>Karo</strong> <strong>Bio</strong>: 250,000<br />
Number of shares in <strong>Karo</strong> <strong>Bio</strong> after the rights<br />
issue: 333,333<br />
Maria Öhlander (1968)<br />
Vice President Clinical Development. Employed since<br />
2007.<br />
Education: M Sc in <strong>Bio</strong>logy.<br />
Primary experience: Clinical Research Manager<br />
Pharmacia & Upjohn, Clinical Project Manager and<br />
Study Delivery Director AstraZeneca, Director Clinical<br />
Operations and Principal Project Manager <strong>Karo</strong><br />
<strong>Bio</strong> AB.<br />
Number of shares in <strong>Karo</strong> <strong>Bio</strong>: 2,666<br />
Number of shares in <strong>Karo</strong> <strong>Bio</strong> after the rights<br />
issue: 13,554<br />
Maria Sjöberg (1964)<br />
Vice President, Chief Scientific Officer, Preclinical<br />
R&D. Employed since 2011.<br />
Education: Ph.D., Associate Professor<br />
Previous experience: R&D/Production Director<br />
SentoClone AB, Senior Scientist Astra Zeneca <strong>Bio</strong>tech,<br />
Section Head/ Project Leader <strong>Karo</strong><strong>Bio</strong> AB,<br />
Group Leader <strong>Karo</strong>linska Institutet.<br />
Number of shares in <strong>Karo</strong> <strong>Bio</strong>: 33,750<br />
Number of shares in <strong>Karo</strong> <strong>Bio</strong> after the rights<br />
issue: 45,000<br />
Henrik Palm (1958)<br />
Chief Financial Officer. Employed since 2011.<br />
Education: Bachelor of Business Administration,<br />
University of Gothenburg.<br />
Previous experience: Business controller within the<br />
Ericsson group (1982-2000), CFO Elektronik Gruppen<br />
BK AB (publ) (2000-2009) and CFO Feelgood<br />
Svenska AB (publ) (2009-2010).<br />
Number of shares in <strong>Karo</strong> <strong>Bio</strong>: 0<br />
Number of shares in <strong>Karo</strong> <strong>Bio</strong> after the rights<br />
issue: 100,000<br />
Lars Öhman (1957)<br />
Vice President Business Development. Employed by<br />
<strong>Karo</strong> <strong>Bio</strong> since 1989. Active as a consultant since<br />
2012.<br />
Education: MBA Stockholm School of Economics.<br />
Chemical Engineering, Royal Institute of Technology.<br />
Previous experience: Project leader and manager<br />
within <strong>Karo</strong> <strong>Bio</strong>’s research- and development organization.<br />
Number of shares in <strong>Karo</strong> <strong>Bio</strong>: 28,660<br />
Number of shares in <strong>Karo</strong> <strong>Bio</strong> after the rights<br />
issue: 38,213<br />
Auditors<br />
Auditors are elected by the <strong>Annual</strong> General Meeting<br />
for a term of one year. The auditors review the company’s<br />
accounting and management on behalf of the<br />
AGM.<br />
PricewaterhouseCoopers AB were elected auditors at<br />
the AGM in June 2012 for the period until the end of the<br />
AGM in 2013. Auditor-in-charge is since April 2008<br />
authorized public accountant Håkan Malmström.<br />
KARO BIO <strong>Annual</strong> <strong>Report</strong> 2012 43
Change language